Canbex Therapeutics Limited – Share Option Agreement by Admin in Uncategorised

 

Theobald Associates is pleased to announce the successful completion of a share option agreement between its London-based client Canbex Therapeutics Limited and Ipsen, a global speciality-driven Biopharmaceutical. The transaction involved Ipsen paying Euro €6 million up front for the option to purchase 100% of the issued share capital of Canbex at completion of Phase 11a study of its lead compound. Further details can be found HERE